ICANN is now accepting applications for new generic Top-Level Domains (gTLDs), which could quickly increase in number from the mere two-dozen or so existing gTLDs which presently include .com, .net, .org, and .biz.

Anti-piracy legislation in both the U.S. House (H.R. 3261, Stop Online Piracy Act, or “SOPA”) and Senate (S.968 PROTECT IP Act, or “PIPA”) has been abruptly halted following this past Wednesday’s worldwide online blackout protest involving numerous popular Internet sites, tweets, blogs, and the like (including WIKIPEDIA).  There has also been growing domestic concern over the potential extent of the federal government's reach in its effort to address rogue overseas websites.

Thursday, 05 January 2012 14:09

LICENSING INFORMATION FOR PCT APPLICATIONS

Written by

Happy New Year! 

As of January 1, 2012 the World Intellectual Property Organisation (WIPO) is now permitting international PCT applicants who are interested in licensing their inventions to request that the International Bureau to make this information publicly available. 

Yesterday, the United States Supreme Court heard oral arguments in the case of Mayo Collaborative Services v. Prometheus Laboratories, Inc., in which Mayo petitioned the Court to determine whether claims of Prometheus' patent directed to optimizing dosage levels of thiopurine for the treatment of various autoimmune disorders is patent eligible subject matter under 35 U.S.C. 101.  More specifically, the claims call for "administering" a certain amount of thiopurine to a patient and "determining" from the resulting metabolite level whether or not to increase or decrease the dosage.

Wednesday, 30 November 2011 21:34

PASSING OF THE LIPITOR PATENT

Written by
Today, a U.S. patent covering the cholesterol drug Lipitor® expires. During the life of the patent, Pfizer, which owns the ground-breaking drug and the patents thereto, could prevent others, namely generic drug makers, from offering or selling drugs in the U.S. that fall within the protected claims of the patent. As of today, with the expiration of the patent, Pfizer’s exclusivity for this particular patented drug formulation ends, opening the arena for generic competitors to enter the marketplace.

Although the sunrise period has passed for brand owners from outside the adult entertainment industry to pay a one-time fee to block the registration of “.xxx” domain names matching their federally registered trademarks, many companies are now considering whether to directly purchase their .xxx domain name, and perhaps variations thereof, for “defensive” purposes. 

Tuesday, 08 November 2011 21:32

FEDERAL CIRCUIT REJECTS "CAPABILITY" ARGUMENT

Written by

In a precedential opinion issued this past Friday, the United States Court of Appeals for the Federal Circuit rejected arguments that an accused device merely needs to be "capable" of being configured or programmed to perform a claimed function in order for patent infringement to occur.

Tuesday, 18 October 2011 21:32

XXX DOMAIN: BLOCKING YOUR BRAND NAME/ TRADEMARK

Written by

Most of our clients have secured the “.com” domain name corresponding to their trademarks, but there are other top level domains such as “.net, “.org,” and “.biz.” While we usually do not recommend securing every possible domain, there is a new “.xxx” extension that is causing concern among trademark owners. From now until October 28, 2011 brand owners from outside the adult entertainment industry have the opportunity to pay a one-time fee to block the registration of “.xxx” domain names matching their federally registered trademarks. Generally, the names can remain blocked for at least the next 10 years. Of course, many technicalities and conditions apply in this blocking process, so please consider this to be general information only. For more information on how to proceed directly with approved registrars, visit the .xxx registry’s website, http://www.icmregistry.com/. If you would like our assistance, our estimated fees to assist with this domain blocking process would be $625.